SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694187-20-000062
Filing Date
2020-05-06
Accepted
2020-05-06 21:05:45
Documents
1
Period of Report
2020-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158881352702970.html 4  
1 FORM 4 wf-form4_158881352702970.xml 4 11569
  Complete submission text file 0001694187-20-000062.txt   12979
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Issuer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEON THERAPEUTICS, INC. 40 ERRIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address
O'Dowd Hugh (Reporting) CIK: 0001741171 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38551 | Film No.: 20854243